# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA804914 | F | Minimum inhibitory concentration against human rhinovirus serotype 21 | human rhinovirus serotype 21 | 2 | organism-based format | Scientific Literature | ||
2. | ALA847823 | F | Expanded antirhinoviral activity against the rhinovirus serotype 21 | rhinovirus A21 | 1 | organism-based format | Scientific Literature | ||
3. | ALA847824 | F | Tested for antirhinoviral activity against the rhinovirus serotype 21 | rhinovirus A21 | 11 | organism-based format | Scientific Literature | ||
4. | ALA4012796 | F | Antiviral activity against Human rhinovirus A21 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay | rhinovirus A21 | 41 | cell-based format | Scientific Literature | ||
5. | ALA4036488 | F | Antiviral activity against human rhinovirus 21 infected in human H1HeLa cells assessed as reduction in virus-induced cytopathicity incubated for 3 days by MTT assay | rhinovirus A21 | 23 | cell-based format | Scientific Literature | ||
6. | ALA4199670 | F | Antiviral activity against Human rhinovirus A21 infected in human H1HeLa cells assessed as inhibition of viral replication after 3 days by MTT assay | rhinovirus A21 | 26 | organism-based format | Scientific Literature | ||
7. | ALA5146826 | F | Antiviral activity against Human rhinovirus A21 infected in human H1-HeLa cells assessed as reduction in virus induced cytopathic effect incubated for 3 days by MTT assay | rhinovirus A21 | 11 | organism-based format | Scientific Literature |